Adherence to insulin therapeutic regimens in patients with type 1 diabetes. A nationwide survey in Brazil
Adherence to insulin therapeutic regimens in patients with type 1 diabetes. A nationwide survey in Brazil
复制标题
DOI:
10.1016/j.diabres.2016.07.011
复制
发表时间:
2016-10-01
影响因子:
5.1
通讯作者:
Negrato, C. A.
中科院分区:
文献类型:
--
作者:
Gomes, M. B.;Negrato, C. A.
Aims: Determine the relationship between self-reported adherence to insulin therapeutic regimens in Brazilian patients with type 1 diabetes and demographic, clinical data, glycemic control and cardiovascular risk factors.Methods: This was a cross-sectional, multicenter study conducted between August 2011 and August 2014 in 10 Brazilian cities. Data were obtained from 1698 patients, aged 30.0 +/- 11.90 years (55.5% females, 53.6% Caucasians) with a diabetes duration of 15.4 +/- 1.9 years. Adherence was evaluated using an adapted 4-item Morisky Medication Scale (MMAS) questionnaire.Results: A total of 166 (9.8%), 717 (42.2%) and 815 (48.0%) of the patients reported maximal (group 0), moderate (group 1) and minimal (group 2) adherence to their insulin therapeutic regimen, respectively. A significant difference in HbA1c was observed in patients from group 2, 9.2 +/- 2.2% (77 +/- 25 mmol/mol) compared to group 1, 8.9 +/- 2.0% (74 +/- 22 mmol/mol) and group 0, 8.6 +/- 1.9% (71 +/- 21 mmol/mol) (p = 0.003). A multivariate logistic analysis revealed that the significant independent variables related to higher insulin therapeutic regimen adherence were older age, higher adherence to diet, lower rate of self-reported hypoglycemia in the last month, low economic status and living in the Southeast region. Insulin therapeutic regimens, number of daily insulin injections, self-monitoring of blood glucose, gender, ethnicity and cardiovascular risk factors were not related to adherence.Conclusions: Most Brazilian T1D patients did not adhere to their prescribed insulin therapeutic regimen, according to the MMAS 4-item scale. This tool should be initially used to identify non-adherent patients and help them overcome the barriers to adherence to their prescriptions. (C) 2016 Elsevier Ireland Ltd. All rights reserved.